» Articles » PMID: 7678301

B Epitopes and Selection Pressures in Feline Immunodeficiency Virus Envelope Glycoproteins

Overview
Journal J Virol
Date 1993 Feb 1
PMID 7678301
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In order to map linear B epitopes in feline immunodeficiency virus (FIV) envelope glycoproteins (Env), a random library of FIV Env polypeptides fused to beta-galactosidase and expressed in Escherichia coli was screened by using sera from experimentally FIV-infected cats. We mapped five antibody-binding domains in the surface envelope glycoprotein (SU1 to SU5) and four in the transmembrane envelope glycoprotein (TM1 to TM4). Immunological analysis with 48 serum samples from naturally or experimentally infected cats of diverse origins revealed a broad group reactivity for epitopes SU2, TM2, and TM3, whereas SU3 appeared as strictly type specific. To study selection pressures acting on the identified immunogenic domains, we analyzed structural constraints and distribution of synonymous and nonsynonymous mutations (amino acids unchanged or changed). Two linear B epitopes (SU3 and TM4) appeared to be submitted to positive selection for change, a pattern of evolution predicting their possible involvement in antiviral protection. These experiments provide a pertinent choice of oligopeptides for further analysis of the protective response against FIV envelope glycoproteins, as a model to understand the role of antibody escape in lentiviral persistence and to design feline AIDS vaccines.

Citing Articles

Diagnostic Accuracy of a Point-of-Care Immunoassay for Feline Immunodeficiency Virus Antibodies, Feline Leukemia Virus Antigen, and Antigen.

Singh S, Davenport K, Schooley E, Ruggiero A, Nassar S, Buch J Viruses. 2023; 15(10).

PMID: 37896893 PMC: 10612086. DOI: 10.3390/v15102117.


Decreased Sensitivity of the Serological Detection of Feline Immunodeficiency Virus Infection Potentially Due to Imported Genetic Variants.

Frankenfeld J, Meili T, Meli M, Riond B, Helfer-Hungerbuehler A, Bonzli E Viruses. 2019; 11(8).

PMID: 31370217 PMC: 6722909. DOI: 10.3390/v11080697.


Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus.

Beczkowski P, Hughes J, Biek R, Litster A, Willett B, Hosie M J Gen Virol. 2014; 96(Pt 4):893-903.

PMID: 25535323 PMC: 4361796. DOI: 10.1099/vir.0.000035.


Mapping of the CXCR4 binding site within variable region 3 of the feline immunodeficiency virus surface glycoprotein.

Sundstrom M, White R, de Parseval A, Sastry K, Morris G, Grant C J Virol. 2008; 82(18):9134-42.

PMID: 18596086 PMC: 2546885. DOI: 10.1128/JVI.00394-08.


Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.

Giannecchini S, DUrsi A, Esposito C, Scrima M, Zabogli E, Freer G Clin Vaccine Immunol. 2007; 14(8):944-51.

PMID: 17596431 PMC: 2044484. DOI: 10.1128/CVI.00140-07.


References
1.
Nei M, Gojobori T . Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986; 3(5):418-26. DOI: 10.1093/oxfordjournals.molbev.a040410. View

2.
Risler J, Delorme M, Delacroix H, Henaut A . Amino acid substitutions in structurally related proteins. A pattern recognition approach. Determination of a new and efficient scoring matrix. J Mol Biol. 1988; 204(4):1019-29. DOI: 10.1016/0022-2836(88)90058-7. View

3.
Goudsmit J, Debouck C, Meloen R, Smit L, Bakker M, Asher D . Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc Natl Acad Sci U S A. 1988; 85(12):4478-82. PMC: 280453. DOI: 10.1073/pnas.85.12.4478. View

4.
Brunner D, Pedersen N . Infection of peritoneal macrophages in vitro and in vivo with feline immunodeficiency virus. J Virol. 1989; 63(12):5483-8. PMC: 251221. DOI: 10.1128/JVI.63.12.5483-5488.1989. View

5.
Pedersen N, TORTEN M, Rideout B, Sparger E, Tonachini T, Luciw P . Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection. J Virol. 1990; 64(2):598-606. PMC: 249149. DOI: 10.1128/JVI.64.2.598-606.1990. View